Acute profound thrombocytopenia after use of eptifibatide for coronary stenting.
This is a case report of a patient who developed profound thrombocytopenia during treatment with eptifibatide after PCI of the mid right coronary artery.
Salengro
Emmanuel
E
Unité de Cardiologie Interventionelle, Clinique Pasteur, Toulouse, France.
Mulvihill
Niall T
NT
Farah
Bruno
B
D000368:Aged; D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects*; D019917:Blood Vessel Prosthesis Implantation / Q000009:adverse effects*; D023921:Coronary Stenosis / Q000188:drug therapy* / Q000601:surgery*; D000077542:Eptifibatide; D006801:Humans; D008297:Male; D010455:Peptides / Q000009:adverse effects* / Q000627:therapeutic use; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D015607:Stents / Q000009:adverse effects*; D013921:Thrombocytopenia / Q000139:chemically induced*
D010455:Peptides; D010975:Platelet Aggregation Inhibitors; D000077542:Eptifibatide